Safety/Quality

Latest Issue of OR Manager
September 2024
Home Safety/Quality

Who is most at risk for long COVID-19?

Editor's Note In this study, Japanese researchers found that COVID-19 severity is not a risk factor for long COVID-19, but older age is. Analysis of responses to a questionnaire survey from 127 recovered patients found that: 52% had sequelae at a median of 29 days from COVID-19 onset, and prevalence…

Read More

By: Judy Mathias
May 19, 2022
Share

The Joint Commission posts reminder to submit applications for Bernard J. Tyson Award

Editor's Note The Joint Commission, on May 18, posted a reminder for organizations to submit applications for the Bernard J. Tyson National Award for Excellence in Pursuit of Health Equity, an award program in partnership with Kaiser Permanente, by June 30 at 11:59 pm CT. The Award, named in honor…

Read More

By: Judy Mathias
May 19, 2022
Share

Session: Financial implications of unprofessional behavior in the OR

Editor's Note In this presentation, Lynn Webb, PhD, assistant dean for faculty development and assistant professor of Medical Education and Administration at Vanderbilt University Medical Center, made a compelling argument for how unprofessional behavior on the part of clinical staff—including OR personnel—has a direct impact on the financial performance of…

Read More

By: Tarsilla Moura
May 18, 2022
Share

Effect of ‘serenity lounges’ on nurse stress, burnout during COVID-19

Editor's Note This study by nurse researchers from Cedars-Sinai Medical Center in Los Angeles evaluates the effect of “serenity lounges” (ie, dedicated rooms where nurses can take breaks to relax and rejuvenate) and massage chairs on nurse anxiety, stress, and burnout, during the COVID-19 pandemic. The researchers analyzed 67 paired…

Read More

By: Judy Mathias
May 12, 2022
Share

Sponsored Message

The Joint Commission asks HCWs to remain masked while interacting with surveyors, reviewers

Editor's Note The Joint Commission, on May 11, announced that surveyors and reviewers will remain masked, adhere to social distancing, and follow other Centers for Disease Control and Prevention guidelines while onsite at an organization. The Joint Commission asks that healthcare workers (HCWs) and organization staff also remain masked while…

Read More

By: Judy Mathias
May 12, 2022
Share

COVID-19 linked to ICU admissions of children, adolescents with self-harm

Editor's Note This Australian study finds that the COVID-19 pandemic was associated with a significant increase in ICU admissions of children and adolescents with deliberate self-harm. Of 813 study patients aged 12 to 17 years, 230 (15.2%) were admitted during the first 15 months of the COVID-19 pandemic. Among the…

Read More

By: Judy Mathias
May 12, 2022
Share

Sponsored Message

The Joint Commission posts Top 5 most challenging requirements for 2021

Editor's Note The Joint Commission, on May 11, posted the Top 5 requirements that were most frequently identified as “not compliant” during surveys and reviews in 2021. The Top 5 for Hospitals were: IC.02.02.01 EP 2: The hospital reduces the risk of infections associated with medical equipment, devices, and supplies.…

Read More

By: Judy Mathias
May 12, 2022
Share

Omicron BA.2.12.1 subvariant gaining a foothold

Editor's Note Though new COVID-19 cases linked to the Omicron BA.2 subvariant are dropping, Omicron’s more infectious subvariant BA2.12.1 is beginning to gain a foothold in the US, the May 10 Becker’s Hospital Review reports. Omicron BA2.12.1 now accounts for nearly 43% of new cases as of May 7, compared…

Read More

By: Judy Mathias
May 11, 2022
Share

FDA: Class I recall of certain Accula SARS-CoV-2 Tests

Editor's Note The Food and Drug Administration (FDA) on May 9 identified the recall by Mesa Biotech, Inc, of certain Accula SARS-CoV-2 Tests as Class I, the most serious. The recall was initiated because certain lots of the PCR test have an increased risk of giving false positive results because…

Read More

By: Judy Mathias
May 11, 2022
Share

FDA limits use of J&J COVID-19 vaccine because of TTS risk

Editor's Note The Food and Drug Administration (FDA) on May 5 announced that it has limited the authorized use of Johnson & Johnson’s Janssen COVID-19 vaccine to those 18 years of age and older for whom other COVID-19 vaccines are not accessible or clinically appropriate and to those who would…

Read More

By: Judy Mathias
May 10, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat